DEF 14A: MSP Recovery Sets 2025 Annual Meeting Agenda: Director Re-election and Auditor Ratification Amidst Strategic Updates and Related Party Disclosures

MSP Recovery, Inc. announced its 2025 Annual Meeting of Stockholders for August 8, 2025, where shareholders will vote on the re-election of three Class III directors and the ratification of Deloitte & Touche LLP as the independent auditor, while the company continues to develop new technology platforms and manage significant related-party financial arrangements.

Summary

• The 2025 Annual Meeting of Stockholders will be held virtually on Friday, August 8, 2025, at 10:00 a.m. Eastern Time.
• Shareholders of record as of June 11, 2025, are entitled to vote on the re-election of Class III directors John H. Ruiz, Frank C. Quesada, and Ophir Sternberg for terms expiring in 2028.
• Shareholders will also vote on the ratification of Deloitte & Touche LLP as the independent registered public accounting firm for the 2025 fiscal year.
• As of March 31, 2025, the company is entitled to a portion of recovery rights associated with approximately $1,592 billion in Billed Amount and approximately $380 billion in Paid Amount, which contains approximately $87.8 billion in Paid Value of Potentially Recoverable Claims.
• The estimated total potentially serviceable market for the company is over $161.5 billion annually, with a primary focus on Medicare and Medicaid segments.
• The company estimates that at least 10% of the approximately $1,029.8 billion spent annually by Medicare in 2023 was improperly paid by private Medicare plans.
• The 'Chase to Pay' platform, designed to improve payment accuracy, has not yet generated revenue.
• The Electronic Health Record (EHR) platform went live in the second quarter of 2024, but revenue generated from it has not been significant.
• The Audit Committee has authorized management to initiate a process to acquire external auditing services proposals for the year ending December 31, 2025, and expects to select a new independent registered public accounting firm.
• CEO John H. Ruiz's salary was restored to $1.8 million effective January 1, 2024, after a voluntary reduction to $0.04 million from June 26, 2023.
• The company has significant related-party transactions, including a $112.8 million unsecured promissory note to MSP Principals (John H. Ruiz and Frank C. Quesada) and a $4.95 million unsecured promissory note to the Law Firm, an affiliate.
• Interest expense related to VRM Full Return was $188.0 million in 2024 and $156.2 million in 2023, and for Virage MTA Amendment was $124.7 million in 2024 and $65.3 million in 2023.

Sentiment

Score: 4

Explanation: The document presents a mixed picture. While it highlights significant market opportunity, advanced technology, and strong corporate governance, it also reveals that key new platforms have not yet generated revenue, and there are substantial related-party transactions with high interest expenses. The potential change in auditors could also be viewed negatively, suggesting underlying issues or cost pressures. The heavy reliance on the MSP Act also presents a significant regulatory risk. The overall tone is promotional for the annual meeting and the company's mission, but the financial details and operational status of new ventures indicate challenges in monetization and high related-party debt.

Positives

• The company maintains a strong corporate governance framework, with 71% independent directors and 100% independent Audit and Compensation Committees.
• Policies are in place prohibiting hedging, pledging, or short sales of company stock for directors, officers, and employees, enhancing financial integrity.
• The company possesses a substantial portfolio of claims rights, totaling approximately $1,592 billion in Billed Amount and $87.8 billion in Paid Value of Potentially Recoverable Claims as of March 31, 2025.
• Proprietary Algorithms and advanced data analytics platforms provide a unique competitive advantage in identifying and recovering improper healthcare payments.
• Strategic development of innovative platforms like 'Chase to Pay' and the 'MSP/Palantir Clearinghouse Platform' aims to enhance payment accuracy and operational efficiency in the healthcare system.
• The EHR Platform went live in Q2 2024, demonstrating continued technological advancement.
• The company's business model, based on irrevocable assignments of claims, allows it to pursue additional legal recoveries, including double damages and statutory interest, which differentiates it from competitors.
• Operating in a growing market, the Centers for Medicare & Medicaid Services projects health spending to increase at an average rate of 5.6% annually between 2023 and 2032, indicating a favorable market trend.

Negatives

• The 'Chase to Pay' platform, a key strategic initiative, has not yet generated revenue.
• The Electronic Health Record (EHR) platform, despite going live in Q2 2024, has not generated significant revenue.
• A substantial portion of expected recoveries (90.2%) is dependent on the Medicare Secondary Payer Act, making the business vulnerable to changes in these laws.
• The company has considerable related-party transactions, including a $112.8 million unsecured promissory note to MSP Principals and a $4.95 million unsecured promissory note to the Law Firm, which can raise concerns about financial transparency and potential conflicts of interest.
• High interest expenses were incurred from related parties, with $188.0 million for VRM Full Return and $124.7 million for Virage MTA Amendment in 2024.
• The Audit Committee's decision to seek proposals for external auditing services for 2025 suggests a potential change from Deloitte, which could indicate underlying financial or governance issues, or cost pressures.

Risks

• Future results may differ materially from past results due to various uncertainties and risks, including those detailed in the 'Risk Factors' and 'Management's Discussion and Analysis of Financial Condition and Results of Operations' sections of the 2024 Annual Report.
• Calculated Billed Amount or Paid Amount values, particularly when extrapolated, may be contested by opposing parties, potentially impacting recovery amounts.
• The termination of data access rights would substantially impair the company's ability to generate recoveries on assigned claims.
• Changes to the laws on which recoveries are based, especially the Medicare Secondary Payer Act, can adversely affect the business, given that 90.2% of expected recoveries rely on this act.
• The company's ability to generate future revenue is significantly dependent on factors outside its direct control.
• Increasing complexity in reimbursement models and healthcare coverage could lead to a rise in the complexity and number of claims, potentially impacting the demand for the company's solutions and its results of operations.

Future Outlook

The company projects continued growth in its serviceable market, driven by increasing healthcare spending, with the Centers for Medicare & Medicaid Services forecasting a 5.6% annual growth rate between 2023 and 2032. It anticipates that increasing complexity in reimbursement models and healthcare coverage will further impact demand for its solutions. The company expects its 'Chase to Pay' platform to substantially improve payment propriety and decrease legal costs of recovery, leading to improved net recovery margins once implemented.

Management Comments

• "MSP Recovery has always been synonymous with our commitment to innovation, integrity, and excellence in the healthcare reimbursement recovery space . . . our decade-long effort to reduce healthcare costs and improve efficiency aligns with the initiatives of the Department of Government Efficiency (DOGE)." John H. Ruiz, CEO.

Industry Context

The company operates within the U.S. healthcare reimbursement industry, which is characterized by significant spending (Medicare $1,029.8 billion, Medicaid $871.7 billion in 2023) and increasing complexity. Its focus on recovering improper payments aligns with broader industry efforts to reduce waste, fraud, and abuse, and manage rising healthcare costs. The projected 5.6% annual growth in health spending by CMS indicates a growing market for the company's services. The company's use of AI, NLP, and ML in its platforms (e.g., Palantir Clearinghouse) reflects a trend towards technology-driven solutions in healthcare data management and payment integrity, positioning it within the health tech and legal tech sectors. Its reliance on the Medicare Secondary Payer Act highlights the significant regulatory influence on this niche.

Comparison to Industry Standards

• The company's claim portfolio of approximately $87.8 billion in Paid Value of Potentially Recoverable Claims as of March 31, 2025, is substantial, and it believes it would take competitors significant time to amass a similar portfolio due to its volume of claims data and data analytics strength.
• The company differentiates itself from competitors by receiving recovery rights through irrevocable assignments of claims, allowing it to assume risk and act as the plaintiff, pursuing additional legal theories like double damages and statutory interest, which competitors operating under third-party vendor service contracts typically cannot.
• The company's estimate that at least 10% of Medicare's annual expenditures are improperly paid by private Medicare plans suggests a significant market inefficiency that its solutions aim to address, potentially indicating a large opportunity compared to general industry recovery rates.
• The collaboration with Palantir for the clearinghouse platform leverages advanced AI/ML capabilities, positioning the company at the forefront of technological innovation in healthcare data analytics, a trend seen across various industries for efficiency gains.

Management Changes

Corporate Governance

Legal Proceedings

• The company is the plaintiff in actions filed to pursue recoveries, stemming from irrevocable assignments of claims.
• The company has achieved landmark legal victories and new Medicare Secondary Payer Act precedent in cases such as MSP Recovery, LLC v. Allstate Ins. Co. (11th Cir. 2016); MSPA Claims 1, LLC v. Tenet Fla. Inc. (11th Cir. 2019); MSPA Claims 1, LLC v. Kingsway Amigo Ins. Co. (11th Cir. 2020); and MSP Recovery Claims, Series LLC v. ACE Am. Ins. Co. (11th Cir. 2020).
• John H. Ruiz led the legal strategy in the landmark victory handed down by the U.S. Court of Appeals for the Eleventh Circuit in MSP Recovery Claims, Series LLC v. ACE Am. Ins. Co. (11th Cir. 2020).
• John H. Ruiz has certified more than 100 class actions and led the company's participation in several key cases.
• John H. Ruiz filed class-action lawsuits on behalf of more than 30,000 Miami-Dade County residents against the Florida Department of Agriculture, resulting in direct compensation to the aggrieved class.
• John H. Ruiz represented consumers in a class action lawsuit against Firestone that settled for more than $30 million.

Related Party Transactions

• An unsecured promissory note of $112.8 million was issued to John H. Ruiz (CEO) and Frank C. Quesada (CLO) in 2022, bearing 4% annual interest, with $5.0 million in interest expense recorded in both 2024 and 2023.
• A portion of the promissory note, $36.5 million, was advanced to the Law Firm (an affiliate of certain Members) for operating expenses, with the balance amortized to $0 as of December 31, 2024.
• The Law Firm, an affiliate, provides legal services for claims recovery in exchange for a portion of recovered proceeds, resulting in a $1.8 million payable to the Law Firm as of December 31, 2024.
• Professional fees related to the Law Firm were $7.7 million in 2024 and $19.2 million in 2023.
• An unsecured promissory note of $4.95 million was issued to the Law Firm in 2023 for general operational funding, with a partial repayment of $0.4 million made on March 4, 2024, for property taxes on collateral pledged by MSP Principals.
• Costs of Claims recoveries related to the Law Firm were $3.4 million in 2024 and $0.3 million in 2023.
• $0.8 million was due from the Law Firm (Affiliate Receivable) as of December 31, 2024 and 2023.
• The Company rents office space from the Law Firm.
• $0.2 million was due from MSP Recovery Aviation, LLC (an affiliate) as of December 31, 2024 and 2023, with $0.2 million in General and Administrative expenses related to MSP Aviation in both years.
• $19.8 million was due to affiliates, primarily Series MRCS, as of December 31, 2024 and 2023 (Affiliate Payable).
• A note payable of $0.5 million to Series MRCS existed as of December 31, 2024 and 2023.
• VRM MSP, a related party, incurred interest expenses of $188.0 million (2024) and $156.2 million (2023) for VRM Full Return, and $124.7 million (2024) and $65.3 million (2023) for Virage MTA Amendment.
• The Company issued Class A Common Stock to Virage in satisfaction of obligations, which shares were subsequently purchased by John H. Ruiz.
• MSP Principals (John H. Ruiz and Frank C. Quesada) pledged equity interests, mortgaged real property, and provided personal guaranties as additional collateral for the Working Capital Credit Facility.
• Effective April 26, 2025, 38 Company employees were transferred to the Law Firm, with monthly expenses of approximately $395,000 now borne by the Law Firm, offsetting its liability to the Company.

Stakeholder Impact

• Shareholders will vote on key corporate governance matters, including director re-election and auditor ratification, directly influencing the company's oversight and strategic direction. The significant related-party transactions and high interest expenses could impact shareholder value and perception of financial health.
• Employees, specifically 38 individuals, were transferred to an affiliated Law Firm as part of a corporate restructuring plan, though their salaries, benefits, titles, and responsibilities remained unchanged, indicating a shift in employment structure.
• Customers (Assignors) may benefit from the company's ongoing efforts to improve payment accuracy and efficiency through platforms like Chase to Pay and the Palantir Clearinghouse, potentially leading to reduced improper payments and streamlined processes.
• Suppliers and partners, such as Palantir and Virage, are impacted by ongoing strategic collaborations and significant financial obligations, including substantial interest payments.
• Creditors face considerations regarding the company's financial leverage due to substantial loans from related parties and high interest expenses, which could influence their assessment of repayment capacity. The pledging of collateral by MSP Principals for the Working Capital Credit Facility indicates efforts to secure financing.

Next Steps

• Stockholders will vote on the re-election of Class III directors (John H. Ruiz, Frank C. Quesada, Ophir Sternberg) at the Annual Meeting.
• Stockholders will vote on the ratification of Deloitte & Touche LLP as the independent registered public accounting firm for 2025.
• The Audit Committee will select and appoint a new independent registered public accounting firm after reviewing proposals for 2025 auditing services.
• The company will continue efforts in connection with the Corporate Restructuring Plan, including the integration of transferred employees into the Law Firm's operations.
• The company is working to increase the number of Assignors that provide daily data outputs for the Chase to Pay platform.
• The company is in the process of determining the pricing and form of arrangements for the Chase to Pay platform.
• The company intends to issue equity awards under the Incentive Plan.

Key Dates

Recommendation

Keywords

Healthcare Reimbursement, Data Analytics, SEC Filing, Proxy Statement, Medicare Secondary Payer Act, MSP Recovery, Corporate Governance, Related Party Transactions, Executive Compensation, Audit Committee, Palantir, AI, Machine Learning, EHR Platform, Claims Recovery, Shareholder Meeting, Deloitte, Risk Management, Financial Reporting